AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1824707
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta-estradiol (Estraderm; 0, 50, 100, or 150 micrograms/day) combined with oral medroxyprogesterone acetate (10 mg each day) during weeks 3-4 and 7-8 of each 8-week regimen
Trial: 28746186
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone for patients with PIV >=8
Trial: 19405936
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy with concurrent chemotherapy (docetaxel)
Trial: 16922703
Drug: Moderate daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate daily amount of red wine
Trial: 11471853
Drug: Zolpidem (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (10 mg/day)
Trial: 11471853
Drug: Zopiclone (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone (7.5 mg/day)
Trial: 8291963
Drug: Intrathecal baclofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal baclofen (high doses > 1,000 micrograms/d)
Trial: 3174151
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 5 mg in 5 ml of saline
Trial: 31516025
Drug: Unencapsulated formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unencapsulated formulations
Trial: 29420164
Drug: Apalutamide (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apalutamide (240 mg per day)
Trial: 22927165
Drug: Ibuprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (600 mg taken four times a day for 1 week)
Trial: 22927165
Drug: No ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: No ibuprofen
Trial: 21626222
Drug: Cyclosporine A
RxNorm normalized name: CycloSPORINE A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine A (CyA) at an initial dose of 5 mg/kg for 12 months
Trial: 21626222
Drug: Methylprednisolone (MP)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MP) 3 pulses of 30 mg/kg followed by prednisone for 4 months
Trial: 21626222
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (identical treatment without randomization)
Trial: 10783653
Drug: Inhaled NO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled NO
Trial: 10430735
Drug: Intravenous PGI(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous PGI(2)
Trial: 10783653
Drug: Systemic calcium
RxNorm normalized name: Vaginal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic calcium antagonists (CAAs)
Trial: 10783653
Drug: Long-term therapy
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term therapy with aerosolized iloprost
Trial: 7582384
Drug: Dispersible diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dispersible diclofenac (100 mg)
Trial: 7582384
Drug: Enteric-coated diclofenac
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enteric-coated diclofenac (100 mg)
Trial: 399090
Drug: Synalar cream
RxNorm normalized name: Synalar Cream
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synalar cream (fluocinolone acetonide 0.025%)
Trial: 399090
Drug: Cortoderm ointment
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cortoderm ointment (fluocinolone acetonide 0.025%)
Trial: 31140297
Drug: Neratinib 240
RxNorm normalized name: NERATINIB
DrugBank: Neratinib (DB11828)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Neratinib 240 mg/day for 1 year after trastuzumab-based adjuvant therapy
Trial: 31140297
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for 1 year after trastuzumab-based adjuvant therapy
Trial: 30305078
Drug: Integrated motivational
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated motivational interviewing and cognitive behaviour therapy (MI-CBT)
Trial: 30238433
Drug: Riociguat 2
RxNorm normalized name: riociguat 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riociguat 2 mg
Trial: 21139557
Drug: Topical corticotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticotherapy with mometasone furoate ointment applied once daily for 4 weeks + emollient cream applied twice a day for 4 weeks
Trial: 21139557
Drug: Topical corticotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticotherapy with mometasone furoate ointment applied once daily for 4 weeks
Trial: 15654072
Drug: Premenopausal women
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premenopausal women taking a combined monophasic oral contraceptive
Trial: 10416734
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g anhydrous dextrose plus 4 mg sodium saccharin
Trial: 10416734
Drug: 23.7 mg
RxNorm normalized name: vardenafil 20 MG (vardenafil HCl 23.7 MG) Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23.7 mg saccharin alone
Trial: 7437263
Drug: Intravenous prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous prednisolone (doses of 16, 32, 48, and 64 mg)
Trial: 7437263
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (100 mg)
Trial: 7437263
Drug: Intravenous prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous prednisolone (all doses)
Trial: 31076261
Drug: Alirocumab 75/150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75/150 mg or 150 mg every 2 weeks
Trial: 29899426
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg once/day (group A)
Trial: 29899426
Drug: Levofloxacin 200
RxNorm normalized name: Levofloxacine
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin 200 mg twice/day (group B)
Trial: 20055751
Drug: Intravenous ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ibandronate (ACE 12 mg; 3 mg every 3 months and 2 mg every 2 months)
Trial: 20055751
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral ibandronate (ACE 5.5 mg; 2.5 mg daily)
Trial: 20055751
Drug: Intravenous ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ibandronate (ACE 12 mg)
Trial: 17394255
Drug: Single intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intramuscular injection of 0.6 mg/kg dexamethasone
Trial: 16360965
Drug: Carvedilol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (50 mg/day for ≤75 kg or 100 mg/day for >75 kg)
Trial: 7317308
Drug: Behaviour therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behaviour therapy with Imipramine
Trial: 7317308
Drug: Behaviour therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behaviour therapy with placebo
Trial: 7317308
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy with Imipramine
Trial: 29781483
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil 0.31 g d‐1
Trial: 29781483
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil 0.62 g d‐1
Trial: 29781483
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil 1.24 g d‐1
Trial: 26707220
Drug: 13-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine
DrugBank: Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (DB10289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine (PCV/PPV)
Trial: 26707220
Drug: 23-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae type 1 capsular polysaccharide antigen
DrugBank: Streptococcus pneumoniae type 1 capsular polysaccharide antigen (DB10319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent pneumococcal polysaccharide vaccine (PPV) only
Trial: 11668312
Drug: Doxycycline (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (150 mg daily)
Trial: 7780294
Drug: 40‐mg intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40‐mg intravenous cocaine injections
Trial: 3182119
Drug: Tulobuterol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tulobuterol (2 mg, twice daily)
Trial: 3182119
Drug: Fenoterol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (2.5 mg, thrice daily)
Trial: 24820831
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no probiotic medication)
Trial: 22285946
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg CLMWF
Trial: 18669464
Drug: Sunitinib (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib (50 mg orally once daily for 4 weeks, followed by 2 weeks off)
Trial: 18669464
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa (9 million units subcutaneous injections, three times weekly)
Trial: 12736474
Drug: Torasemide at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torasemide at 4-8 mg/day
Trial: 12736474
Drug: Furosemide at
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide at 20-40 mg/day
Trial: 10230947
Drug: Calcium chloride
RxNorm normalized name: Calcium Chloride
DrugBank: Calcium chloride (DB01164)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium chloride (CaCl2) 10 mg/kg administered simultaneously with propofol
Trial: 10230947
Drug: Saline administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline administered simultaneously with propofol
Trial: 8653836
Drug: Hydralazine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine at 10 μg/min (control)
Trial: 7904993
Drug: Roxatidine 75
RxNorm normalized name: roxatidine 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxatidine 75 mg twice daily
Trial: 7904993
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg 3 times a day and 400 mg at bed time
Trial: 3327445
Drug: Intravenous indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous indomethacin 0.35 mg/kg followed by an infusion of 0.07 mg/kg/h for 24 h
Trial: 31948661
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acid (O-3FA) 4 g/day
Trial: 23057804
Drug: IV ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV ibuprofen (10 mg/kg on day 1, 5 mg/kg on day 2, and 5 mg/kg on day 3)
Trial: 6628498
Drug: Propranolol (2-16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (2-16 mg)
Trial: 6628498
Drug: Pindolol (0.2-1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (0.2-1.6 mg)
Trial: 31292608
Drug: levcromakalim (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levcromakalim (0.05 mg/min)
Trial: 28203319
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (37 mg of elemental iron daily for 3 weeks)
Trial: 25791612
Drug: Mirabegron administered
RxNorm normalized name: Mirabegron
DrugBank: Mirabegron (DB08893)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mirabegron administered as a single oral dose under fasted conditions.
Trial: 25791612
Drug: Mirabegron administered
RxNorm normalized name: Mirabegron
DrugBank: Mirabegron (DB08893)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mirabegron administered once daily under fed conditions for 8 days after a washout period.
Trial: 25791612
Drug: Mirabegron administered
RxNorm normalized name: Mirabegron
DrugBank: Mirabegron (DB08893)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mirabegron administered with low-fat and high-fat meals.
Trial: 14679118
Drug: Cisplatin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (25 mg/m²) and Docetaxel (20 mg/m²) administered on days 1, 8, and 15 every 4 weeks
Trial: 11354452
Drug: Additional scrubbing
RxNorm normalized name: Scrub-Stat
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Additional scrubbing of toe clefts with a gauze swab soaked in topical antiseptic.
Trial: 11354452
Drug: Standard preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard preparation with antiseptic between the toes.
Trial: 7905101
Drug: Intraarterial infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraarterial infusion of 17 beta‐oestradiol
Trial: 7905101
Drug: Patch administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Patch administration of 17 beta‐oestradiol
Trial: 7905101
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of oestradiol
Trial: 3139909
Drug: 6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg/kg Euphyllin (theophylline)
Trial: 3139909
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg Euphyllin (theophylline)
Trial: 22906685
Drug: Physostigmine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine (1 mg/h)
Trial: 12560299
Drug: alfentanil 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alfentanil 20 microg x kg(‐1), lidocaine 1.5 mg x kg(‐1), propofol 3 mg x kg(‐1) (Group I; n = 40)
Trial: 12560299
Drug: fentanyl 2
RxNorm normalized name: fentanyl 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fentanyl 2 microg x kg(‐1), lidocaine 1.5 mg x kg(‐1), propofol 3 mg x kg(‐1) (Group II; n = 40)
Trial: 10716371
Drug: 350 microg
RxNorm normalized name: Norethindrone 350 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 microg of the lipopeptide immunogen administered on days 0, 28, and 56 to HLA-selected subjects (4 subjects)
Trial: 10716371
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered according to a similar inoculation schedule to HLA-selected subjects (3 subjects)
Trial: 10716371
Drug: 350 microg
RxNorm normalized name: Norethindrone 350 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 microg of the lipopeptide immunogen administered to HLA-mismatched subjects (2 subjects)
Trial: 3544940
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg body weight diazepam (Group A)
Trial: 3544940
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg body weight midazolam (Group B)
Trial: 17391383
Drug: Amoxycillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin-clavulanic acid 625 mg, four times daily for 3 days
Trial: 17391383
Drug: Amoxycillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin-clavulanic acid 625 mg, four times daily for 10 days
Trial: 16141426
Drug: Dipyridamole/Aspirin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole/Aspirin (200 mg dipyridamole/25 mg aspirin twice a day)
Trial: 16141426
Drug: Dipyridamole/Aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole/Aspirin
Trial: 215011
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of double stranded RNA from f2-phage
Trial: 25693055
Drug: Corticosteroids for
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids for ∼9 months and a maximum of six 500‐mg fixed‐dose intravenous (IV) cyclophosphamide (CYC) pulses, every 2‐3 weeks, then maintenance azathioprine or methotrexate.
Trial: 25693055
Drug: Corticosteroids for
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids for ∼26 months combined with 500 mg/m2 IV CYC pulses, every 2‐3 weeks until remission, then maintenance for GPA or MPA patients and for those with EGPA or PAN with a Five‐Factors Score (FFS) of ≥1.
Trial: 11179125
Drug: Cumulative dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative dose of salbutamol (400 microg)
Trial: 11179125
Drug: Cumulative dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative dose of salbutamol (800 microg)
Trial: 11179125
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of salbutamol (50, 100, or 400 microg)
Trial: 11179125
Drug: Cumulative dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative dose of salbutamol (50+50+100+200 or 100+100+200+400 or 400+0+0+0 or 0+0+0+0 microg)
Trial: 9788413
Drug: Irradiation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irradiation with doses under 50 Gy in T1-2 tumors
Trial: 9788413
Drug: Irradiation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irradiation with doses below 50 Gy in T3-4 tumors
Trial: 9788413
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of irradiation and wide local tumor excision
Trial: 8141197
Drug: 0.75% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% metronidazole gel 5 gm twice daily for 5 days
Trial: 18656571
Drug: Stage of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stage of change (action vs contemplation/preparation)
Trial: 18656571
Drug: Daily servings
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily servings of fruit and vegetable intake
Trial: 18656571
Drug: Understanding of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Understanding of vitamin pills
Trial: 8706450
Drug: Active drug
RxNorm normalized name: Capillary active drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active drug (polymerized bovine hemoglobin)
Trial: 8706450
Drug: Control infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control infusion of lactated Ringer's solution
Trial: 6360817
Drug: Prostaglandin synthesis
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin synthesis inhibitors (acetylsalicyclic acid or indomethacin) during cytostatic infusion
Trial: 29985202
Drug: High-intensity statin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity statin, maximally tolerated angiotensin-converting-enzyme inhibitor or angiotensin receptor blocker, and low-dose aspirin
Trial: 29985202
Drug: Conservative empiric
RxNorm normalized name: aspirin / codeine phosphate Oral Tablet [Empirin with Codeine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative empiric treatment or further diagnostic evaluation of the coronary microvasculature
Trial: 29985202
Drug: Traditional antianginal
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional antianginal and antiatherosclerotic medications
Trial: 19470941
Drug: nab-paclitaxel 100
RxNorm normalized name: paclitaxel 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nab-paclitaxel 100 mg/m(2) weekly
Trial: 19470941
Drug: nab-paclitaxel 150
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: nab-paclitaxel 150 mg/m(2) weekly
Trial: 19495958
Drug: nab-paclitaxel 300
RxNorm normalized name: NAB-PACLITAXEL COMPONENT PACLITAXEL
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: nab-paclitaxel 300 mg/m(2) q3w
Trial: 16533865
Drug: Paroxetine (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (21 days treatment)
Trial: 8938165
Drug: Ultrasound-guided percutaneous
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided percutaneous acetic acid injection (15%, 20%, 30%, 40%, and 50% concentration)
Trial: 8938165
Drug: Percutaneous acetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous acetic acid injection alone
Trial: 8938165
Drug: Percutaneous acetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous acetic acid injection after transcatheter arterial embolization